FindTrial
Sign In

Analysis of related factors that affect early DGE after Ivor-Lewis treatment for patients with esophageal carcinoma

Analysis of related factors that affect early DGE after Ivor-Lewis treatment for patients with esophageal carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015276
Enrollment
Unknown
Registered
2018-03-20
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal carcinoma

Interventions

DGE Group:Albumin detection
Congrol Group:Albumin detection

Sponsors

Shangqiu First People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients with esophageal cancer confirmed by preoperative gastroscopy, ultrasound, CT, esophageal barium-swallow imaging, histopathology and other tests; 2. esophageal cancer patients with TNM stage IIa-IIIa; 3. patients who received MIILE.

Exclusion criteria

Exclusion criteria: 1. patients suffering from serious infectious diseases such as tuberculosis and/or cardiopulmonary infarction and other serious organic diseases; 2. patients with preoperative chronic gastrointestinal disease; 3. patients histopathologically diagnosed with stage I and IV esophageal cancer; 4. patients with incomplete medical records.

Design outcomes

Primary

MeasureTime frame
Albumin;—

Countries

China

Contacts

Public ContactCao Jiwei

Shangqiu First People's Hospital

desenliu57@hotmail.com+86 0771-5310057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026